[1] 朱裕林,宋立中,邢蓉,等.盐酸左氧氟沙星注射液致休克死亡1例[J].中国医院药学杂志,2016,36(5):423~424. [2] 朱航,雷迅,张帆,等.左氧氟沙星治疗耐多药肺结核疗效与安全性的系统评价[J].中国循证医学杂志,2012,12(2):201~208. [3] 王淑英.盐酸左氧氟沙星导致不良药物反应的相关因素分析[J].中国医药指南,2013,11(20):16~17. [4] 王欢欢,沈绍清.左氧氟沙星致严重中枢神经系统不良反应1例[J].海南医学,2016,27(6):1022~1023. [5] W Wen,D M,Zhao X H,Zhang,et al.One-step fabrication of poly(oaminophenol)/muti-walled carbon nanotubes composite film modified electrode and its application for levofloxacin determination in pharma-ceuticals[J].Sensors and Actuators B,2012,174(9):202~209. [6] 郭玉姝,韦劲,胡光瑞.医院88例左氧氟沙星注射液不良反应特点分析[J].中国药业,2016,25(20):82~83. [7] 严小燕.乳酸左氧氟沙星氯化钠注射液不良反应分析[J].江苏医药,2015,41(5):598. [8] Croisier D,Etienne M,Bergoin E.Mutantselection window in levofloxacinand moxifloxacin treatments of experimental pheumococcal pneumonia ina rabbit model of human therapy[J].AntimicrobAgents Chemother,2014,48(05):1699~1707. [9] Hovde LB,Rotschafer SE,Ibrahin KI,et al.Mutation prevention concentration of ceftriaxone,meropenem,impenem andertapcnem[J].DiagnMicrobiol Infect Dis,2013,15(12):265~267. [10] Lu T,Zhao X,Li X,et al.Effect of chloramphenicol,erythromycin,moxifloxacin,penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus[J].Antimicrob Chemother,2013,52(01):61~64. [11] 李新江,付玉叶.盐酸左氧氟沙星所导致不良反应的类型、临床表现及应对措施[J].中外医疗,2017,6(12):146~148. [12] Sieradzki K,Roberts RB,Haber SW,et al.The development of vancomycin resistancein a patient with methicillin-resistant Staphylococcus aureusinfection[J].N Engl Med,2014,340(07):517~523. [13] 何红月.盐酸左氧氟沙星治疗盆腔炎的临床疗效观察及安全性分析[J].中国妇幼保健,2015,30(30):5283~5285. [14] Schmitz FJ,Jones ME,Homfann B,etal.Characteriztion of grl A,grl B,gyr A,and gyr B mutations in 116 unrelated isolates of Staphylococcus aureus and effectsof mutations on ciprofloxacin MIC[J].Antimicrob Agents Chemother,2013,42(5):1249~1252. [15] 聂大平,董枫,石宏宴.左氧氟沙星、环丙沙星单用和联合其他抗菌药物对铜绿假单胞菌防突变浓度的研究[J].中国感染控制杂志,2007,6(6):397~400. [16] 刘建华.三种静脉注射左氧氟沙星方法的不良反应发生情况比较[J].国际护理学杂志,2016,35(8):1148~1149. [17] 刘芳,马香芹,杨丽娜,等.我院常用喹诺酮类药物的心脏不良反应分析[J].中国药房,2017,28(5):625~629. [18] Allen GP,Deshpande LM.Determination of the mutant selection windowfor clindamycin,doxycycline,linezolid,moxifloxacin andtrimethoprim/Sulfamethoxazoleagainst community-associated methicillin-resistant Staphylococcus aureus(MRSA)[J].Int Antimicrob Agents,2015,35(1):45~49. [19] 陈崇泽.12例左氧氟沙星致心血管不良反应分析[J].药物评价研究,2013,36(6):485~487. [20] 朱丽华,沈华美.注射用左氧氟沙星不良反应的护理体会[J].护士进修杂志,2013,28(4):374.
2017, Vol. 23 
冀公网安备13080202000677号